RuferMHandIAlslebenHBraatzAOrtmannJKatenkampB, and others. Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo. Eur Arch Psychiatry Clin Neurosci2005;255:121–8.
2.
FoaEBLiebowitzMRKozakMDaviesSCampeasRFranklinME, and others. Randomized, placebo controlled trial, of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry2005;162:151–61.
3.
Pediatric OCD Treatment study (POTS). Cognitive-behavior therapy, sertraline and their combination for children and adolescents with obsessive-compulsive disorder. Randomized controlled trial. JAMA2004;16:1969–76.
4.
KampmanMKeijsersGPJHoogduinCALVerbraakMJPM. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine. Acta Psychiatr Scand2002;106:314–9.
5.
FranklinMSimpsonHB. Combining pharmacotherapy and exposure plus ritual prevention for obsessive compulsive disorder: Research findings and clinical applications. Journal of Cognitive Psychotherapy: An International Quarterly2005;1:317–30.
6.
SalkovskisP.Obsessional-compulsive problems: A cognitive-behavioural analysis. Behav Res Ther1985;23:571–83.
7.
SookmanDPinardGBeckAT. Vulnerability schemas in obsessive-compulsive disorder. Journal of Cognitive Psychotherapy: An International Quarterly2001;15:109–30.
8.
ShafranRThordarsonDSRachmanS.Thought-action fusion in obsessive-compulsive disorder. J Anxiety Disord1996;10:379–91.
9.
SookmanDPinardG.Integrative cognitive therapy for obsessive-compulsive disorders: A focus on multiple schemas. Cogn Behav Pract1999;6:351–62.
10.
RadomskyATaylorS.Subtyping OCD: Prospects and problems. Behav Ther2005;36:371–81.
11.
HollanderEBenzaquenS.Is there a distinct OCD spectrum?CNS Spectrums1996;1:17–25.
12.
AbelsonJLCurtisGCSagherOAlbucherRCHarriganMTaylorSF, and others. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry2005;57:510–6.